Clinicians should consider prioritising review for people with type 2 diabetes on the affected GLP-1 RA preparation where: HbA1c greater than 86mmol/mol in the previous 3 to 6 months HbA1c greater than 86mmol/mol prior to starting the GLP1-RA HbA1c not recorded in the previous 6 months Urine albumin creatinine ratio (uACR) greater than 30mg/mmol Self-monitoring glucose readings (or Continuous Glucose Monitoring, where available) are persistently above individualised target range
Luchsinger JA, Devanand D, Goldberg TE, Cammack S, Hernndez-Santiago G, Oishi K, et al
Covalent heterobivalent inhibitor design for inhibition of IgE-Dependent penicillin allergy in a murine model
Diabetes (2007) 56:294657
Researchers have discovered that GIP is crucial in regulating vascular and cardiac function and lipid metabolism
While it is not classified as a traditional GLP-1 receptor agonist, Zepbound works similarly by influencing hunger signals, promoting satiety, and supporting weight loss